孕早期联合筛查在8-10周与11-13周预测早发型和早产型子痫前期的诊断准确性
本研究为前瞻性队列研究的二次分析,纳入2641例单胎妊娠,比较孕8-10周与11-13周检测PAPP-A和PlGF对早发型和早产型子痫前期的预测能力。结果显示,两种算法下,生物标志物检测时间对预测准确性无显著差异,支持两步法风险评估。
要点
- 孕8-10周与11-13周检测PAPP-A和PlGF对早发型和早产型子痫前期的预测准确性相似。
- 高斯算法和FMF竞争风险模型下,AUC无显著差异(除PAPP-A+MAP组合预测早发型PE外)。
- 可采用两步法:孕早期超声时即可计算风险,无需等待血清结果。
核心结论
- 孕8-10周与11-13周检测血清标志物对早发型和早产型子痫前期的预测准确性相似。
研究设计与样本
- 前瞻性队列研究的二次分析,纳入2641例单胎妊娠,来自西班牙巴塞罗那Vall d'Hebron大学医院,2015年10月至2017年9月。
主要发现
- 共90例(3.4%)发生子痫前期,其中早发型11例(0.4%),早产型30例(1.1%)。
- 早发型子痫前期中,5例(45.5%)在8-10周组,6例(54.5%)在11-13周组;早产型中,16例(53.3%)在8-10周组,14例(46.7%)在11-13周组。
- 高斯算法预测早发型和早产型PE时,生物标志物检测时间前后AUC无差异。
- FMF算法预测时,除PAPP-A+MAP组合预测早发型PE外(11周后检测AUC更高),其他组合AUC无差异。
关键数值与推荐
- 在5%和10%假阳性率下计算检出率,但具体数值未在摘要中报告。
临床怎么用
- 孕早期联合筛查可采用两步法:在11-13周超声时记录临床和生物物理指标,同时可立即计算风险,无需等待血清生物标志物结果。
局限性
- 本研究为二次分析,样本来自单中心,结果需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the ability of first-trimester combined screening for pre-eclampsia (PE) to predict early-onset and preterm PE when pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF) were assessed before vs after 11 weeks' gestation. METHODS: This was a secondary analysis of a prospective cohort study of singleton pregnancies undergoing routine first-trimester screening conducted at Vall d'Hebron University Hospital, Barcelona, Spain, between October 2015 and September 2017. Demographic characteristics, obstetric history, maternal history and biophysical markers (mean uterine artery pulsatility index and mean arterial blood pressure (MAP)) were recorded at the first-trimester scan (at 11 + 0 to 13 + 6 weeks' gestation). Maternal serum concentrations of PAPP-A and PlGF were assessed from the routine first-trimester blood test (at 8 + 0 to 13 + 6 weeks). Women were classified into two groups depending on whether serum biomarkers were assessed at 8 + 0 to 10 + 6 weeks or at 11 + 0 to 13 + 6 weeks. Probability scores for early-onset and preterm PE were calculated by using two different algorithms: the multivariate Gaussian-distribution model and The Fetal Medicine Foundation (FMF) competing-risks model. Receiver-operating-characteristics (ROC) curves were produced and detection rates at fixed 5% and 10% false-positive rates were computed to compare the performance of these algorithms when PAPP-A and PlGF were assessed before vs after 11 weeks. RESULTS: Of the 2641 women included, serum biomarkers were assessed before 11 weeks in 1675 (63.4%) and at or after 11 weeks in 966 (36.6%). Of these, 90 (3.4%) women developed PE, including 11 (0.4%) cases of early-onset PE and 30 (1.1%) of preterm PE. Five (45.5%) cases of early-onset and 16 (53.3%) of preterm PE were identified in the group in which serum biomarkers were assessed at 8 + 0 to 10 + 6 weeks and six (54.5%) cases of early-onset and 14 (46.7%) of preterm PE in the group in which serum biomarkers were assessed at 11 + 0 to 13 + 6 weeks. In the prediction of early-onset and preterm PE using the Gaussian algorithm, no differences were observed between the areas under the ROC curves (AUCs) when PAPP-A and PlGF were measured before or after 11 weeks. In the prediction of early-onset and preterm PE using the FMF algorithm, no differences were observed between AUCs for any of the combinations used for risk calculation when the serum biomarkers were obtained before vs after 11 weeks, except for the combination of PAPP-A and MAP, which showed a greater AUC for the prediction of early-onset PE when PAPP-A was measured at or after 11 weeks. CONCLUSIONS: The prediction of early-onset and preterm PE is similar when serum biomarkers are measured before or after 11 weeks. This allows the use of a two-step approach for PE risk assessment that permits immediate risk calculation at the time of the first-trimester scan. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Mendoza M, Garcia-Manau P, Arévalo S, et al. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2021. PMID: 32388877. doi:10.1002/uog.22071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。